Patent: 4,822,609
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,822,609
Title: | Treatment of osteoporosis |
Abstract: | A method for treating or preventing osteoporosis is disclosed. Bone cells are synchronized during a bone cell activating period; bone resorption, which normally follows activation, is inhibited using a polyphosphonate; bone formation is allowed to occur in the rest period during which nutrient supplements may be administered to the patient. The method shortens the natural cycle time of bone formation/resorption, resulting in a faster bone build-up. |
Inventor(s): | Flora; Lawrence (Fairfield, OH) |
Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
Application Number: | 06/906,725 |
Patent Claims: | see list of patent claims |
Details for Patent 4,822,609
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2006-04-18 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |